Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.


Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
29 09 2020
Historique:
received: 04 08 2020
accepted: 16 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 25 6 2021
Statut: epublish

Résumé

Bias in randomized controlled trials (RCTs) can lead to underestimation or overestimation of the true effects of interventions. Surgical RCTs may suffer from the risk of bias (RoB) that is avoidable in trials of other interventions, and vice versa. We aimed to compare the adequacy of RoB assessments in surgical versus non-surgical RCTs included in Cochrane reviews and to assess the most common differences in those RoB assessments. Due to specificities of surgical trials, i.e. difficulties associated with blinding of surgical interventions, we hypothesized that assessments of surgical trials may be more adequate, compared to RCTs of non-surgical interventions. This was a methodological study, analyzing methods of published Cochrane systematic reviews. Data were extracted from RoB tables in Cochrane reviews (judgments and accompanying explanatory comment) for the following four RoB domains used in the 2011 Cochrane RoB tool: randomization, allocation concealment, blinding of participants and personnel, and blinding of outcome assessors. We defined adequate assessments as those that were in line with instructions from the Cochrane Handbook for Systematic Reviews of Interventions. The prevalence of adequate assessments was compared in surgical versus non-surgical trials. The most common differences in both groups of reviews were presented. In 729 analyzed Cochrane reviews, there were 10,537 included trials. The prevalence of adequate RoB judgments made by Cochrane authors ranged from 87.9, 95%CI (87.3 to 88.6%) for randomization to 70.7, 95%CI (69.8 to 71.5%) for blinding of participants and personnel. For all analyzed RoB domains, the prevalence of adequate RoB domains was higher in surgical trials than in non-surgical trials. For two RoB domains assessing blinding, this difference between surgical and non-surgical trials was statistically significant (P < 0.001), while the difference was not significant for the RoB domain regarding randomization (P = 0.124) and allocation concealment (P = 0.039, β < 0.8). RoB judgments were more in line with instructions from the Cochrane Handbook when Cochrane reviews assessed surgical trials, compared to those that analyzed non-surgical interventions. However, further steps are warranted to scrutinize RoB assessment in trials of both surgical and non-surgical interventions.

Sections du résumé

BACKGROUND
Bias in randomized controlled trials (RCTs) can lead to underestimation or overestimation of the true effects of interventions. Surgical RCTs may suffer from the risk of bias (RoB) that is avoidable in trials of other interventions, and vice versa. We aimed to compare the adequacy of RoB assessments in surgical versus non-surgical RCTs included in Cochrane reviews and to assess the most common differences in those RoB assessments. Due to specificities of surgical trials, i.e. difficulties associated with blinding of surgical interventions, we hypothesized that assessments of surgical trials may be more adequate, compared to RCTs of non-surgical interventions.
METHODS
This was a methodological study, analyzing methods of published Cochrane systematic reviews. Data were extracted from RoB tables in Cochrane reviews (judgments and accompanying explanatory comment) for the following four RoB domains used in the 2011 Cochrane RoB tool: randomization, allocation concealment, blinding of participants and personnel, and blinding of outcome assessors. We defined adequate assessments as those that were in line with instructions from the Cochrane Handbook for Systematic Reviews of Interventions. The prevalence of adequate assessments was compared in surgical versus non-surgical trials. The most common differences in both groups of reviews were presented.
RESULTS
In 729 analyzed Cochrane reviews, there were 10,537 included trials. The prevalence of adequate RoB judgments made by Cochrane authors ranged from 87.9, 95%CI (87.3 to 88.6%) for randomization to 70.7, 95%CI (69.8 to 71.5%) for blinding of participants and personnel. For all analyzed RoB domains, the prevalence of adequate RoB domains was higher in surgical trials than in non-surgical trials. For two RoB domains assessing blinding, this difference between surgical and non-surgical trials was statistically significant (P < 0.001), while the difference was not significant for the RoB domain regarding randomization (P = 0.124) and allocation concealment (P = 0.039, β < 0.8).
CONCLUSIONS
RoB judgments were more in line with instructions from the Cochrane Handbook when Cochrane reviews assessed surgical trials, compared to those that analyzed non-surgical interventions. However, further steps are warranted to scrutinize RoB assessment in trials of both surgical and non-surgical interventions.

Identifiants

pubmed: 32993499
doi: 10.1186/s12874-020-01123-7
pii: 10.1186/s12874-020-01123-7
pmc: PMC7526117
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

240

Références

BMC Med Res Methodol. 2019 Apr 11;19(1):77
pubmed: 30971219
Br J Oral Maxillofac Surg. 2013 Dec;51(8):913-9
pubmed: 23746677
Eur J Orthod. 2016 Jun;38(3):308-12
pubmed: 26174770
Can J Surg. 2010 Oct;53(5):345-8
pubmed: 20858381
J Clin Epidemiol. 2020 Jul;123:114-119
pubmed: 32247026
J Clin Epidemiol. 2019 Aug;112:53-58
pubmed: 31009658
Eur J Cancer. 2014 May;50(7):1330-44
pubmed: 24650579
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
J Comp Eff Res. 2020 Jun;9(8):585-593
pubmed: 32459105
BMC Med Res Methodol. 2019 Apr 5;19(1):76
pubmed: 30953448
Plast Reconstr Surg. 2016 Feb;137(2):696-706
pubmed: 26818309
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
J Clin Epidemiol. 2019 Feb;106:10-17
pubmed: 30312657
Br J Surg. 2009 Apr;96(4):342-9
pubmed: 19283747
J Clin Epidemiol. 2020 Mar;119:57-64
pubmed: 31734347
J Clin Epidemiol. 2020 Apr;120:25-32
pubmed: 31866473
Evid Based Child Health. 2014 Dec;9(4):1052-9
pubmed: 25504975
BMC Med Res Methodol. 2019 Aug 5;19(1):170
pubmed: 31382898
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Clin Epidemiol. 2019 Sep;113:104-113
pubmed: 31132470

Auteurs

Ognjen Barcot (O)

Department of Surgery, University Hospital Split, Split, Croatia.

Matija Boric (M)

Department of Surgery, University Hospital Split, Split, Croatia.

Svjetlana Dosenovic (S)

Department of Anesthesiology and Intensive Care, University Hospital Split, Split, Croatia.

Marija Cavar (M)

Department of Radiology, University Hospital Split, Split, Croatia.

Antonia Jelicic Kadic (A)

Department of Pediatrics, University Hospital Split, Split, Croatia.

Tina Poklepovic Pericic (T)

Cochrane Croatia, University of Split School of Medicine, Split, Croatia.

Ivana Vukicevic (I)

Postgraduate doctoral program, University of Zagreb School of Dental Medicine, Zagreb, Croatia.

Ivana Vuka (I)

Laboratory for Pain Research, University of Split School of Medicine, Split, Croatia.

Livia Puljak (L)

Center for Evidence-Based Medicine and Health Care, Catholic University of Croatia, Ilica 242, 10000, Zagreb, Croatia. livia.puljak@unicath.hr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH